Background
Twin-twin transfusion syndrome, or TTTS, is a serious complication that can occur in identical twin pregnancies sharing one placenta. In TTTS, abnormal blood vessel connections within the placenta allow blood to flow unevenly between the twins. One twin, called the donor twin, gives away too much blood, while the recipient twin receives too much. Without treatment, TTTS can lead to fetal death or severe illness for one or both babies.
The standard treatment is fetoscopic laser photocoagulation, a minimally invasive procedure in which a thin camera is inserted into the uterus and laser energy is used to seal the abnormal placental blood vessel connections. The goal is to separate the twins’ circulations so each fetus can develop more independently.
Not all placental connections are the same. Some are superficial connections, including artery-to-artery and vein-to-vein anastomoses, while others involve deeper vessel patterns. A key question has been whether the order in which these superficial connections are sealed during surgery affects outcomes. In particular, does it matter if vein-to-vein connections are ablated at the beginning of the procedure or at the end?
Study Objective
This study examined whether the timing of laser treatment for vein-to-vein placental connections was associated with fetal survival after fetoscopic laser therapy for TTTS. The focus was on whether these connections should be sealed first or last during surgery.
Study Design
This was a post hoc analysis, meaning the researchers looked back at data from a previously completed randomized controlled trial called the Sequential Trial. That trial compared two surgical approaches: sequential laser photocoagulation and selective laser photocoagulation.
Inside the main trial, some patients with superficial placental anastomoses were additionally randomized to have those connections ablated either at the beginning of the operation or at the end. For this analysis, researchers specifically examined patients who had vein-to-vein anastomoses and compared them with a reference group of patients who had no superficial anastomoses.
The main outcomes were donor twin survival and recipient twin survival. The investigators also used multiple logistic regression to account for other factors that could influence survival, including the random assignment to “Ablated First” versus “Ablated Last.”
What Are Vein-to-Vein Anastomoses?
Vein-to-vein anastomoses are direct vessel connections in the placenta between the veins of the two twins. Although these connections are less commonly discussed than artery-to-vein connections, they may still affect blood flow patterns within the shared placenta.
During laser surgery, sealing these vessels should help prevent ongoing blood exchange between the twins. However, the timing of when they are sealed may matter, possibly because of temporary changes in placental blood flow during the procedure or because of how the surgeon navigates the placenta.
Key Findings
Out of 642 trial participants, 64 pregnancies, or about 10%, had at least one vein-to-vein anastomosis. The number of such connections ranged from 1 to 3.
Donor twin live birth was lower in the vein-to-vein group than in the group with no superficial anastomoses. Specifically, donor survival was 75.0% in the vein-to-vein group compared with 90.3% in the no superficial anastomoses group.
Among the 64 patients with vein-to-vein connections, 28 were assigned to have these connections ablated first, and 36 were assigned to have them ablated last.
Donor survival differed across the groups:
– No superficial anastomoses: 90.3%
– Ablated First: 82.1%
– Ablated Last: 69.4%
Recipient survival was:
– No superficial anastomoses: 94.2%
– Ablated First: 96.4%
– Ablated Last: 86.1%
The difference in recipient survival was not statistically significant in the unadjusted comparison, but the pattern still suggested worse outcomes when vein-to-vein connections were treated at the end of the procedure.
Adjusted Analysis
When the researchers adjusted for other variables in multivariable logistic regression models, the group in which vein-to-vein anastomoses were ablated last had significantly lower odds of survival compared with the reference group without superficial anastomoses.
For donor survival, the adjusted odds ratio was 0.24, with a 95% confidence interval of 0.10 to 0.58, and the result was statistically significant. This means the donor twin was much less likely to survive when vein-to-vein anastomoses were left until the end of the procedure.
For recipient survival, the adjusted odds ratio was 0.30, with a 95% confidence interval of 0.10 to 0.92, also indicating worse survival in the Ablated Last group.
These findings suggest that the timing of laser treatment for vein-to-vein connections may influence fetal outcomes, with earlier treatment appearing safer in this dataset.
Interpretation
The study raises an important surgical question: should vein-to-vein placental connections be sealed early in fetoscopic laser surgery rather than at the end? The results suggest that end-of-procedure ablation may be associated with poorer survival for both twins, especially the donor twin.
One possible explanation is that leaving vein-to-vein connections open until the end could allow continued abnormal circulation during much of the procedure, when placental blood flow is already being manipulated. Another possibility is that these vessels are markers of more complex placental vascular architecture, making surgery more challenging and outcomes more variable. However, this study was not designed to prove a mechanism.
Because this was a post hoc exploratory analysis, the findings should be interpreted cautiously. Post hoc studies are useful for generating new hypotheses, but they are not as strong as a trial designed specifically to answer the question from the start.
Clinical Significance
TTTS is a high-risk condition, and fetoscopic laser photocoagulation remains the best-established treatment to improve survival and reduce complications. Even small refinements in surgical technique may matter.
If future studies confirm these findings, surgeons may consider prioritizing early ablation of vein-to-vein anastomoses when they are identified during the procedure. This could potentially improve donor and recipient survival, although surgical decisions must still be individualized based on placental anatomy, visibility, and overall procedure strategy.
For patients, the message is not that a specific surgical step alone determines outcome, but that the detailed approach to placental laser therapy may influence the chance of success. This emphasizes the importance of referral to experienced fetal therapy centers.
Limitations
This analysis has several limitations.
First, it was exploratory and performed after the main trial had already been completed. That means the study was not originally powered specifically to examine vein-to-vein timing.
Second, only 64 patients had vein-to-vein anastomoses, which is a relatively small subgroup. Small sample sizes can make results less stable and more sensitive to chance.
Third, the analysis compared this subgroup with patients who had no superficial anastomoses, rather than directly comparing only the “Ablated First” and “Ablated Last” groups in a dedicated randomized design.
Fourth, the study does not explain the biological reason why timing matters. More research is needed to understand whether the result reflects true physiology, surgical complexity, or both.
Conclusion
In this post hoc analysis of the Sequential Trial, treating vein-to-vein placental anastomoses at the end of fetoscopic laser photocoagulation was associated with lower donor and recipient survival in twin-twin transfusion syndrome. The findings suggest that the sequence of ablation may matter and that early treatment of these superficial connections could be beneficial.
Because the study was exploratory, these results should be viewed as hypothesis-generating rather than definitive. Still, they provide useful evidence for future research and may help refine surgical technique in the management of TTTS.
